Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
133.62
-8.22 (-5.80%)
May 7, 2026, 10:14 AM EDT - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.95 billion as of May 7, 2026. Its market cap has increased by 1,035.91% in one year.
Market Cap
1.95B
Enterprise Value
2.05B
1-Year Change
1,035.91%
Ranking
Category
Stock Price
$133.62
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.95B, an increase of 884.59%. That is a compound annual growth rate of 225.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 2.07B | 80.33% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.96B |
| Capricor Therapeutics | 1.94B |
| Taysha Gene Therapies | 1.91B |
| Harmony Biosciences Holdings | 1.89B |
| Galapagos NV | 1.87B |
| Recursion Pharmaceuticals | 1.86B |
| Vericel | 1.86B |
| Generate Biomedicines | 1.84B |